Norovirus Infection of Dendritic Cells and Macrophages
树突状细胞和巨噬细胞的诺如病毒感染
基本信息
- 批准号:7339313
- 负责人:
- 金额:$ 31.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-15 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAntibodiesAppendixAttenuatedAustraliaBacterial GastroenteritisBindingBiologyBone MarrowCOS CellsCOS-7 CellCalicivirusCapsidCapsid ProteinsCarbohydratesCategoriesCell LineCell Surface ProteinsCell Surface ReceptorsCell surfaceCellsCloningCollaborationsCommitConfocal MicroscopyCrystallographyCultured CellsCytoplasmDataDendritic CellsDevelopmentDominant-Negative MutationDrug usageEffectivenessEndocytosisEnteralEnvironmentEpidemicEventFecesFundingGenesGenomeGoalsGrantGrowthHematopoieticHerpesviridaeHumanHybridomasImageImmuneImmunityIncusInfectionKnowledgeLaboratoriesLearningLettersMethodsMolecularMonoclonal AntibodiesMononuclearMusNatural ImmunityNatureNone or Not ApplicableNorovirusNorwalk virusPaperPathogenesisPathway interactionsPhagocytosisPlaque AssayProcessProteinsProteolysisQualifyingQueenslandRNARNA InterferenceReovirusReportingResearchResearch DesignRoleRouteScienceScreening procedureSimplexvirusStructural ProteinStructureStudy SectionSystemTechnologyTestingTransfectionTropismUniversitiesViralVirionVirulenceVirusVirus ReceptorsWashingtonWorkbasecostexperienceexpression cloninggranulocytein vivomacrophagemilligramneutralizing monoclonal antibodiesnovelpathogenpermissivenessreceptorresearch studytissue culturetoolviral RNA
项目摘要
Human noroviruses (type virus Norwalk) are the major cause of epidemic non-bacterial
gastroenteritis in the world. As Category B agents, analysis of their biology is a high priority. However, these
viruses have been difficult to study because they have not been cultured ex vivo. Therefore many
fundamental questions remain about the biology of these viruses. In 2003 we reported the discovery of the
first murine norovirus (MNV-1, Appendix 1, Karst et al., STAT1-dependent innate immunity to a Norwalk-like
virus. 2003. Science. 299:1575-8). We have subsequently found that this efficient enteric virus has a
surprising tropism for dendritic cells and macrophages in vivo, and used this information to develop the first
tissue culture replication system for a norovirus (Appendix 2, Wobus et al., Replication of a Norovirus in cell
culture reveals a tropism for dendritic cells and macrophages. PLOS Biology. E432. Epub Nov 30 2004).
Using this novel system we have developed a plaque assay for MNV-1, plaque purified MNV-1, purified
milligram amounts of virus, obtained the first cryo-EM image of an infectious norovirus, and proved that
MNV-1 RNA is infectious, even in cells that are not permissive for MNV-1 infection. This latter result
indicates that MNV-1 tropism is determined at steps in infection prior to delivery of viral RNA into the
cytoplasm such as binding, entry, or uncoating.
Based on these new data, there are two goals of the Specific Aims. First, we propose to define
fundamental mechanisms of viral entry for a viral genus that has not been studied in detail before. Second,
we seek to define whether differences in these fundamental mechanisms between cells determine MNV-1
cell tropism. The Specific Aims are:
Aim 1. Define the viral events involved in MNV-1 binding, entry, and uncoating.
Aim 2. Define the cellular events involved in MNV-1 binding, entry, and uncoating.
Aim 3. Determine the cellular and molecular basis of MNV-1 cell tropism.
The proposed studies will provide fundamental information about the binding, entry, and uncoating of a
very important genus of viruses that incudes many human pathogens.
人诺如病毒(诺瓦克型病毒)是引起非细菌性流行病的主要原因
世界上最严重的肠胃炎作为B类制剂,对其生物学进行分析是一项高度优先事项。但这些
病毒难以研究,因为它们没有被离体培养。因此许多
关于这些病毒的生物学仍然存在一些基本问题。2003年我们报道了
第一种鼠诺如病毒(MNV-1,附录1,Karst等,STAT 1依赖性天然免疫对诺瓦克样
病毒2003.科学299:1575-8)。我们随后发现,这种有效的肠道病毒具有
树突状细胞和巨噬细胞在体内的惊人的向性,并利用这一信息开发了第一个
诺如病毒的组织培养复制系统(附录2,Wobus等,诺如病毒在细胞中的复制
培养物揭示了树突细胞和巨噬细胞的向性。PLOS Biology. E432 Epub 2004年11月30日)。
使用这种新的系统,我们已经开发了MNV-1的噬斑测定,噬斑纯化的MNV-1,纯化的
毫克数量的病毒,获得了第一个传染性诺如病毒的冷冻电镜图像,并证明,
MNV-1 RNA具有感染性,即使在不允许MNV-1感染的细胞中也是如此。后一种结果
表明MNV-1嗜性是在病毒RNA递送到细胞中之前的感染步骤中确定的。
细胞质,如结合,进入,或脱壳。
根据这些新数据,具体目标有两个目标。首先,我们建议定义
病毒进入病毒属的基本机制,以前没有详细研究过。第二、
我们试图确定细胞之间这些基本机制的差异是否决定了MNV-1
细胞向性具体目标是:
目标1。定义涉及MNV-1结合、进入和脱壳的病毒事件。
目标2.定义参与MNV-1结合、进入和脱膜的细胞事件。
目标3.确定MNV-1细胞嗜性的细胞和分子基础。
拟议的研究将提供有关结合,进入和涂层的基本信息,
包括许多人类病原体的非常重要的病毒属。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HERBERT W VIRGIN其他文献
HERBERT W VIRGIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HERBERT W VIRGIN', 18)}}的其他基金
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
9893810 - 财政年份:2020
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
10364721 - 财政年份:2019
- 资助金额:
$ 31.72万 - 项目类别:
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
10364722 - 财政年份:2019
- 资助金额:
$ 31.72万 - 项目类别:
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
管理核心 - 自噬调节剂作为新型广谱抗感染剂
- 批准号:
10573255 - 财政年份:2019
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
10573254 - 财政年份:2019
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
9893808 - 财政年份:2019
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
8642370 - 财政年份:2014
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
9231379 - 财政年份:2014
- 资助金额:
$ 31.72万 - 项目类别:
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
自噬调节剂作为新型广谱抗感染剂
- 批准号:
9010908 - 财政年份:2014
- 资助金额:
$ 31.72万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.72万 - 项目类别:
Research Grant